FROM POGO (Project on Government Oversight)
Paul Thacker writes about Lovenox , a block buster blood thinner made by Sanofi-Aventis, and Dr. Victor Tapson who plead with the FDA that a generic version of Enoxaparin might not be as safe as the name brand version.
Could their be a reason for this?
Is there a conflict of interest?
Find out by reading Paul Thacker's article at POGO blog.
Subscribe to:
Post Comments (Atom)








0 comments:
Post a Comment